New combo therapy shows promise for tough prostate cancer
NCT ID NCT04126070
First seen Jan 23, 2026 · Last updated May 02, 2026 · Updated 11 times
Summary
This study tests a combination of hormone therapy, chemotherapy (docetaxel), and an immunotherapy drug (nivolumab) in 60 men with metastatic hormone-sensitive prostate cancer that has spread widely. The goal is to see if this triple approach can lower PSA levels more effectively. Participants must have newly diagnosed, high-volume disease with DNA repair defects or inflamed tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
H. Lee Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
The Johns Hopkins University School of Medicine
Baltimore, Maryland, 21218, United States
-
University of California, San Diego
La Jolla, California, 92093, United States
-
University of Wisconsin
Madison, Wisconsin, 53706, United States
Conditions
Explore the condition pages connected to this study.